MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome

被引:7
|
作者
Men, Yu [1 ]
Zhai, Yirui [2 ]
Wu, Lihong [3 ]
Liu, Lipin [4 ]
Zhang, Wenjue [2 ,5 ]
Jiang, Wei [2 ,5 ]
Bi, Nan [2 ]
Song, Yongmei [6 ]
Hui, Zhouguang [1 ]
Wang, Luhua [2 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept VIP Med Serv & Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Genecast Precis Med Technol Inst, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Beijing Hosp, Natl Ctr Gerontol, Inst Geriatr Med,Dept Radiat Oncol, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Beijing, Guangdong, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; miR-323a-3p; FMR1; RHEUMATOID-ARTHRITIS; EXPRESSION; MICRORNA-323-3P; IDENTIFICATION; METASTASIS; BIOMARKER; CANCER; PROGRESSION; INVASION; IMPACT;
D O I
10.1186/s12935-022-02541-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Esophageal squamous cell carcinoma (ESCC) has unfavorable outcomes with the highest incidence seen in China. Accordingly, exploring effective molecular biomarkers is of great value. MicroRNAs (miRNAs) are posttranscriptional regulators of gene expression and modulate numerous biological processes in tumors. Our study aimed to identify prognostic miRNAs and investigate their role in ESCC. Methods Prognosis-related plasma miRNAs were detected by miRNA microarray and qRT-PCR. Functional assays and molecular mechanism studies were used to investigate the role of miRNA in ESCC. Results Over-expression of miR-323a-3p was associated with a favorable prognosis. MiR-323a-3p negatively regulated proliferation, migration, and invasion. Through biological predictions, the fragile X mental retardation 1 (FMR1) was found to be a potential target of miR-323a-3p. Further investigation revealed that miR-323a-3p directly targeted and suppressed FMR1. MiR-323a-3p and FMR1 mRNA, as well as miR-323a-3p and the FMR1-encoded protein FMRP, showed negative correlations. Luciferase activity of FMR1-3 '-UTR, but not mutant counterparts, was decreased by mimic compared with that of the control. The compromised cell proliferation, migration, and invasion induced by transfection with miR-323a-3p mimic were rescued by transfection with a FMR1 expression plasmid. Tumors induced by miR-323a-3p overexpressed ESCC cells grew significantly slower in vivo and resulted in smaller tumor masses. Metastatic lung colonization was also inhibited by miR-323a-3p overexpression. Conclusions MiR-323a-3p was significantly associated with survival and acted as a tumor suppressor by inhibiting proliferation, migration, and invasion via the regulation of FMR1. MiR-323a-3p is a promising biomarker and may be a potential therapeutic target.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome
    Yu Men
    Yirui Zhai
    Lihong Wu
    Lipin Liu
    Wenjue Zhang
    Wei Jiang
    Nan Bi
    Yongmei Song
    Zhouguang Hui
    Luhua Wang
    Cancer Cell International, 22
  • [2] MiR-323a-3p Inhibits Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Via Suppression FMR1
    Men, Y.
    Zhai, Y. R.
    Wu, L.
    Liu, L.
    Bi, N.
    Song, Y.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E610 - E610
  • [3] Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma
    Yi, Yunfeng
    Lu, Xiujuan
    Chen, Jianming
    Jiao, Changjie
    Zhong, Jing
    Song, Zhiming
    Yu, Xiaoping
    Lin, Baoli
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (05) : 3411 - 3416
  • [4] miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma
    Xu, Jianfeng
    Lv, Haiyan
    Zhang, Bo
    Xu, Feng
    Zhu, Hongyu
    Chen, Baofu
    Zhu, Chengchu
    Shen, Jianfei
    JOURNAL OF THORACIC DISEASE, 2019, 11 (07) : 3015 - +
  • [5] PIK3C3 Acts as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and Was Regulated by MiR-340-5p
    Wang, Xiaobo
    Gu, Min
    Ju, Yongjian
    Zhou, Juying
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [6] MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma
    Liu, Jianmin
    Liu, Beibei
    Guo, Yuanyuan
    Chen, Zhijun
    Sun, Wei
    Gao, Wuyue
    Wu, Hongliang
    Wang, Yan
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (06) : 806 - 813
  • [7] Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
    Yu, Xinshuang
    Zhang, Jiandong
    Zhong, Hua
    Liu, Fengjun
    Liang, Ning
    Wang, Yao
    Meng, Xiangjiao
    Du, Juan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2016, 13 (12): : 963 - 969
  • [8] miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma
    Feng, Jie
    Qi, Bo
    Guo, Ling
    Chen, Ling-Yun
    Wei, Xiu-Feng
    Liu, Yu-Zhen
    Zhao, Bao-Sheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (23) : 4243 - 4251
  • [9] Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
    Zhu, Ying-Hui
    Fu, Li
    Chen, Leilei
    Qin, Yan-Ru
    Liu, Haibo
    Xie, Fajun
    Zeng, Tingting
    Dong, Sui-Sui
    Li, Jiangchao
    Li, Yan
    Dai, Yongdong
    Xie, Dan
    Guan, Xin-Yuan
    CANCER RESEARCH, 2013, 73 (07) : 2298 - 2309
  • [10] MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1
    Lohcharoenkal, Warangkana
    Li, Chen
    Das Mahapatra, Kunal
    Lapins, Jan
    Homey, Bernhard
    Sonkoly, Eniko
    Pivarcsi, Andor
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (08) : 1922 - 1931